Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men

AIDS

Volumn 24, Issue 15, 2010, Pages 2355-2363

  Alvarez, Jennifer ^a,b   Pokomandy, Alexandra D E ^c,d   Rouleau, Danielle ^a,b   Ghattas, George ^c,d   Vézina, Sylvie ^e   Coté, Pierre ^f   Allaire, Guy ^a   Hadjeres, Rachid ^a   Franco, Eduardo L ^c   Coutlée, François ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e Clinique Medicale l'Actuel   (Canada)

^f Clinique Medicale du Quartier Latin   (Canada)

Author keywords

anal intraepithelial neoplasia; HIV; human papillomavirus load; human papillomavirus natural history; human papillomavirus type 16; integration; MSM

Indexed keywords

ADULT; AGED; ANAL INTRAEPITHELIAL NEOPLASIA; ANUS TUMOR; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NUCLEOTIDE SEQUENCE; PRECANCER AND CANCER-IN-SITU; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DNA, VIRAL; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; VIRAL LOAD; YOUNG ADULT;

EID: 77957230255     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833db9ea     Document Type: Article

References (51)

1. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12:495-503. (Pubitemid 28116159)
2. Sobhani I, Walker F, Roudot-Thoraval F, Abramowitz L, Johanet H, Hénin D, et al. Anal carcinoma: incidence and effect of cumulative infections. AIDS 2004; 18:1561-1569. (Pubitemid 39037480)
3. Palefsky JM, Holly EA, Efirdc JT, Da-Costa M, Jay N, Berry JM, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19:1407-1414. (Pubitemid 41800677)
4. Critchlow CW, Surawicz CM, Holmes KK, Kuypers J, Daling JR, Hawes SE, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995; 9:1255-1262.
5. Zbar AP, Fenger C, Efron J, Beer-Gabel M, Wexner SD. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis 2002; 17:203-215. (Pubitemid 36075774)
6. Salit I, Tinmouth J, Chong S, Raboud J, Diong C, Su D. Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biom Prev 2009; 18:1986-1992.
7. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361-367. (Pubitemid 28063760)
8. Gohy L, Gorska I, dePokomandy A, Rouleau D, Ghattas G, Allaire G, et al. Genotyping of human papillomavirus in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Def Syndr 2008; 49:32-39.
9. Kiviat NB, Critchlow CW, Holmes KK, Kuypers J, Sayer J, Dunphy C, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS 1993; 7:43-49. (Pubitemid 23069031)
10. de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, Macleod J, et al. Prevalence, clearance and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009; 199:965-973.
11. Rowhani Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, et al. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 2007; 196:887-894. (Pubitemid 47378939)
12. Palefsky JM, Holly EA, Gonzales J, Lamborn K, Hollander H. Natural history of anal cytologic abnormalities and papillomavirus infection among homosexual men with group IV HIV disease. J Acquir Immune Def Syndr 1992; 5:1258-1265. (Pubitemid 23012961)
13. Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, Da Costa MM, Botts R, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr 1998; 17:314-319. (Pubitemid 28145167)
14. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC. Anal intraepithelial neoplasia in heterosexual and homosexual HIVpositive men with access to antiretroviral therapy. J Infect Dis 2004; 190:1685-1691. (Pubitemid 39411020)
15. Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 2002; 185:1229-1237. (Pubitemid 34439129)
16. Snijders PJ, Steenbergen RDM, Heideman DAM, Meijer CJLM. HPV-mediated cervical carcinogenesis: current concepts and clinical implications. J Pathol 2006; 208:152-164.
17. Varnai AD, Bollmann M, Griefingholt H, Speich N, Schmitt C, Bollmann R, Decker D. HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis 2006; 21:135-142. (Pubitemid 43154433)
18. Fontaine J, Hankins C, Money D, Rachlis A, Pourreaux K, Ferenczy A, Coutlee F. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV. J Clin Virol 2008; 43:307-312. (Pubitemid 46052221)
19. Fontaine J, Hankins C, Mayrand MH, Lefevre J, Money D, Gagnon S, et al. High levels of episomal and integrated HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 2005; 19:785-794. (Pubitemid 40834748)
20. Pett M, Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 2007; 212:356-367. (Pubitemid 47099012)
21. Hopman AHN, Smedts F, Dignef W, Ummulen M, Sonke G, Mravunac M, et al. Transition to high-grade cervical intraepithelial neoiplasia to micro-invasive carcinoma is characterized by integration of HPV16/18 and numerical chromosome abnormalities. J Pathol 2004; 202:23-33. (Pubitemid 38072842)
22. Lytwyn A, Salit IE, Raboud J, Chapman W, Darragh T, Winkler B, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005; 103:1447-1456. (Pubitemid 40410742)
23. Azizi N, Brazete J, Hankins C, Money D, Fontaine J, Koushik A, et al. Influence of HPV-16 E2 polymorphism on quantitation of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. J Gen Virol 2008; 89:1716-1728.
24. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006; 44:1755-1762. (Pubitemid 43726265)
25. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferenczy A, et al. Viral load of episomal and integrated forms of Human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix. Int J Cancer 2007; 121:2674-2681. (Pubitemid 350136411)
26. Ruutu MP, Kulmala SM, Peitsaro P, Syrjanen SM. The performance of the HPV16 real-time PCR integration assay. Clin Cancer Res 2008; 41:423-428.
27. Luft F, Klaes R, Nees M, Durst M, Heilmann V, Melsheimer P, von-Knebel-Doeberitz M. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001; 92:9-17. (Pubitemid 32187026)
28. Matovina M, Sabol I, Grubisic G, Gasperov NM, Grce M. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol 2009; 113:120-127.
29. Maciel RM, Kimura ET, Cerutti JM. Pathogenesis of differentiated thyroid cancer (papillary and follicular). Arq Bra Endocrinol Metabol 2005; 49:691-700.
30. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Hogeboom CJ, Darragh TM. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 1997; 73:174-180.
31. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101:270-280.
32. De Marco L, Gillio-Tos A, Bonello L, Ghisetti V, Ronco G, Merletti F. Detection of human papillomavirus type 16 integration in preneoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J Clin Virol 2007; 38:7-13. (Pubitemid 44881419)
33. Fujii T, Masumoto N, Saito M, Hirao N, Niimi S, Mukai M, et al. Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn Mol Pathol 2005; 14:103-108. (Pubitemid 40734078)
34. Nagao S, Yoshinouchi M, Miyagi Y, Hongo A, Kodama J, Itoh S, Kudo T. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol 2002; 40:863-867. (Pubitemid 34208636)
35. Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, et al. A comprehensive analysis of HPV integration lociinanogenital lesionscombiningtranscriptandgenome-based amplification techniques. Oncogene 2003; 22:3977-3984. (Pubitemid 36819671)
36. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999; 59:6132-6136. (Pubitemid 30035633)
37. Herdman MT, Pett MR, Roberts I, AlazawiWO, Teschendorff AE, Zhang XY, et al. Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episomenumbers andemergence of latent integrants. Carcinogen 2006; 27:2341-2353. (Pubitemid 44644825)
38. Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, Stanley MA, Coleman N. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A 2006; 103:3822-3827. (Pubitemid 43376639)
39. Hafner N, Driesch C, Gajda M, Jansen L, Kirchmayr R, Runnebaum IB, Durst M. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 2008; 27:1610-1617. (Pubitemid 351347875)
40. Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 1998; 17:146-153. (Pubitemid 28151014)
41. Huang LW, Chao SL, Lee BH. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J Clin Pathol 2008; 61:627-631.
42. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002; 40:886-891. (Pubitemid 34208640)
43. Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis 2006; 194:1706-1712.
44. Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, et al. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 2007; 20:256-266. (Pubitemid 46422181)
45. Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 2004; 92:873-880. (Pubitemid 38251391)
46. Kulmala S-MA, Syrjanen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi PT, et al. Early integration of high copy HPV-16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2007; 59:513-517.
47. Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, et al. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 2007; 121:2198-2204. (Pubitemid 47585598)
48. Canadas MP, Darwich L, Sirera G, Bofill M, Pinol M, Garcia Cuyas F, et al. Human papillomavirus 16 integration and risk factors associated in anal samples of HIV-1 infected men. Sex Transm Dis 2010; 37:311-315.
49. Yu T, Ferber MJ, Cheung TH, Chung TK, Wong YF, Smith DI. The role of viral integration in the development of cervical cancer. Cancer Genet Cytogenet 2005; 158:27-34. (Pubitemid 40354321)
50. Bechtold V, Beard P, Raj K. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol 2003; 77:2021-2028. (Pubitemid 36110014)
51. Peitsaro P, Hietanen S, Johansson B, Lakkala T, Syrjanen S. Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. Carcinogenesis 2002; 23:1057-1064. (Pubitemid 34752963)